مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

231
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

275
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases

Pages

  310-319

Abstract

 C-C chemokine receptor type 5 (CCR5) is a receptor for some pro-inflammatory Chemokines which plays important roles in immunological disorder and host responses to infectious agents. Additionally, the prognosis of some immune-mediated diseases in the people who are naturally carrying the CCR5 32bp deletions is optimistic. However, the clinical application of CCR5 32bp mutant cells is very limited due to the rare availability of donors who are homozygous for CCR5  32. The Transfection efficiency of nucleofected placental mesenchymal stem cells derived-human induced pluripotent stem cells (PMSC-hiPSCs) was examined through the evaluation of green fluorescent protein (GFP) expression using Flow cytometry. The nucleofected clonal populations were selected using colony picking. The CCR5 gene disrupted clonal populations were evaluated and confirmed by PCR and Sanger sequencing methods. Also, off-target sites were evaluated by the “ Loss of a primer binding site” technique. The results of the Flow cytometry revealed that among the six applied nucleofection programs for PMSC-iPSCs, the program of A-033 has achieved the best Transfection efficiency (27. 7%). PCR and then sequencing results confirmed the CCR5 gene was disrupted in two clonal populations of 16 ( 6) and 62 ( 20) by the Clustered regularly interspaced short palindromic repeats/CRISPR associated nuclease 9 (CRISPR/Cas9) system. The “ Loss of a primer binding site” technique showed that no exonic off-target mutations were induced in both CCR5 gene disrupted clonal populations. We establish a CRISPR/Cas9 mediated CCR5 ablated PMSC-hiPSCs without detectable offtarget damage. This approach can provide a stable supply of autologous/allogeneic CCR5-disrupted PMSC-hiPSCs that might be a feasible approach for the treatment of immune-mediated diseases.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Hosseini Rouzbahani, Negin, KAVIANI, SAEID, VASEI, MOHAMMAD, SOLEIMANI, MASOUD, AZADMANESH, KAYHAN, & NICKNAM, MOHAMMAD HOSSEIN. (2019). Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 18(3), 310-319. SID. https://sid.ir/paper/291577/en

    Vancouver: Copy

    Hosseini Rouzbahani Negin, KAVIANI SAEID, VASEI MOHAMMAD, SOLEIMANI MASOUD, AZADMANESH KAYHAN, NICKNAM MOHAMMAD HOSSEIN. Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2019;18(3):310-319. Available from: https://sid.ir/paper/291577/en

    IEEE: Copy

    Negin Hosseini Rouzbahani, SAEID KAVIANI, MOHAMMAD VASEI, MASOUD SOLEIMANI, KAYHAN AZADMANESH, and MOHAMMAD HOSSEIN NICKNAM, “Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 18, no. 3, pp. 310–319, 2019, [Online]. Available: https://sid.ir/paper/291577/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button